Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

Commercial validation in Europe parallels ongoing RESPONDER-HF clinical trial TEWKSBURY, Mass., Dec. 21, 2024 /PRNewswire/ -- Corvia Medical, Inc., a company dedicated to transforming the treatment of heart failure, announced today that it has...

Health In Tech, Inc. Announces Pricing of Initial Public Offering

Health In Tech, Inc. Announces Pricing of Initial Public Offering

STUART, Fla., Dec. 21, 2024 /PRNewswire/ -- Health In Tech, Inc., an Insurtech platform company backed by third-party AI technology, today announced the pricing of its initial public offering of 2,300,000 shares of its Class A common stock, at a...

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

SAN FRANCISCO and SUZHOU, China, Dec. 20, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...

Call for Entries Issued for 12th Annual Asia-Pacific Stevie® Awards

Call for Entries Issued for 12th Annual Asia-Pacific Stevie® Awards

New Awards Categories for Innovation of Individual Professionals FAIRFAX, Va., Dec. 20, 2024 /PRNewswire/ -- The Stevie® Awards are now accepting nominations for the 2025 (12th annual) Asia-Pacific Stevie® Awards, the only business awards program to...

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

Based on promising early clinical results from PeproMene Bio's PMB-102 Phase 1 study, they will receive $6M USD upfront plus an additional $5M USD in conditional tranched investments from the Institute for Follicular Lymphoma Innovation. Patients...

Digital Realty Empowers Turing's Gaggle Cluster with Optimal Data Center Environment to Fast-Track Full Drive Automation by AI

Digital Realty Empowers Turing's Gaggle Cluster with Optimal Data Center Environment to Fast-Track Full Drive Automation by AI

Robust and flexible platform supporting large-scale GPU cluster for AI-driven autonomous vehicles boosts Turing's speed-to-market by 75% SINGAPORE, Dec. 18, 2024 /PRNewswire/ -- Digital Realty (NYSE: DLR), the largest global provider of cloud- and...

TDH Holdings, Inc. Reports First Half 2024 Financial Results

TDH Holdings, Inc. Reports First Half 2024 Financial Results

BEIJING, Dec. 17, 2024 /PRNewswire/ -- TDH Holdings, Inc. (NASDAQ: PETZ) ("TDH" or the "Company"), a PRC-based company that is an owner, operator and manager of commercial real estate properties, announced today its financial results for the six...

Top Businesses and Leaders in the Philippines Honored at the Asia Pacific Enterprise Awards (APEA) 2024

Top Businesses and Leaders in the Philippines Honored at the Asia Pacific Enterprise Awards (APEA) 2024

MANILA, Philippines, Dec. 13, 2024 /PRNewswire/ -- The Asia Pacific Enterprise Awards (APEA) 2024 Philippines Chapter celebrated the achievements of remarkable Filipino business leaders and enterprises on December 11 at Hilton Manila. Organized by...

Anviz Officially Launches OSDP-Enabled Access Control Solution

Anviz Officially Launches OSDP-Enabled Access Control Solution

FREMONT, Calif., Dec. 14, 2024 /PRNewswire/ -- Anviz (a business unit of Xthings Group, Inc.) has officially launched an OSDP (Open Supervisory Device Protocol)-enabled access control solution. Our goal is simple: improve the shortcomings of legacy...

Snail Games Powers Portfolio Growth with Acquisition of Publishing Rights for Robots at Midnight

Snail Games Powers Portfolio Growth with Acquisition of Publishing Rights for Robots at Midnight

CULVER CITY, Calif., Dec. 13, 2024 /PRNewswire/ -- Snail, Inc. (Nasdaq: SNAL) ("Snail Games" or the "Company"), a leading global independent developer and publisher of interactive digital entertainment, Snail Games is thrilled to announce the...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 14
  • menu
    menu